- Report
- January 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,517GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,253GBP
€1780EUR$2,000USD£1,567GBP
- Report
- October 2025
- 381 Pages
Global
From €5206EUR$5,850USD£4,582GBP
- Report
- September 2025
- 250 Pages
Global
From €3995EUR$4,490USD£3,517GBP
- Report
- July 2025
- 175 Pages
Global
From €3995EUR$4,490USD£3,517GBP
- Report
- June 2025
- 150 Pages
Global
From €2402EUR$2,699USD£2,114GBP
- Report
- June 2024
- 200 Pages
Global
From €5660EUR$6,360USD£4,982GBP
€7074EUR$7,950USD£6,227GBP
- Report
- August 2022
- 35 Pages
Global
From €1780EUR$2,000USD£1,567GBP
- Report
- May 2022
- 32 Pages
Global
From €1780EUR$2,000USD£1,567GBP
- Report
- September 2024
- 78 Pages
Global
From €3500EUR$4,213USD£3,189GBP
The Poisoning Drug market is a subset of the Drugs by Therapeutic Area market, focusing on drugs used to treat poisoning. These drugs are used to treat a variety of poisoning cases, from accidental ingestion of toxic substances to intentional overdose. Poisoning drugs are typically administered in an emergency setting, and can be used to counteract the effects of a wide range of toxins. Common poisoning drugs include activated charcoal, naloxone, and flumazenil.
The Poisoning Drug market is highly competitive, with a number of major players. These include GlaxoSmithKline, Pfizer, Merck, Sanofi, and Novartis. Other companies in the market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more
